Immune Related Adverse Event clinical trials

Explore recruiting immune related adverse event clinical trials.

Recruiting immune related adverse event studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Immune Related Adverse Event trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2–) Breast Cancer (KEYNOTE-756)

Hungary, Spain, France, Ireland, Portugal, Belgium +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants from Multiple Avelumab (MSB0010718C) Clinical Studies

Italy, Bulgaria, Poland, Romania, France, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Immune Related Adverse Event trials by city

Immune Related Adverse Event in Toronto Immune Related Adverse Event in Vancouver Immune Related Adverse Event in Montreal Immune Related Adverse Event in Calgary Immune Related Adverse Event in Edmonton Immune Related Adverse Event in Ottawa Immune Related Adverse Event in Winnipeg Immune Related Adverse Event in Quebec City Immune Related Adverse Event in Hamilton Immune Related Adverse Event in Kitchener Immune Related Adverse Event in London Immune Related Adverse Event in Halifax Immune Related Adverse Event in New York Immune Related Adverse Event in Los Angeles Immune Related Adverse Event in Chicago Immune Related Adverse Event in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease